Clinical trials: Acute Mild Ischemic Stroke, active
Stroke, Stroke, Acute Ischemic
NeuroAiD Patient-Reported Outcomes in Patients With Mild to Moderate Ischemic Stroke
This is a randomized, controlled, open-label study of MLC901 (NeuroAiD™ II) in patients with mild to moderate ischemic stroke. Eligible participants will be randomized in a 1:1 ratio to receive MLC901 in combination with standard…
- Conditions
- Stroke, Stroke, Acute Ischemic, Stroke, Ischemic, Stroke, Cryptogenic
- Trial name
- NAiD-PRO (NCT07828210)
- Testing
- MLC901, Standard treatment for acute ischemic stroke
- Where
- Vietnam
- Volunteers
- 80 people
- Sponsor
- EVD Pharmacy and Medical Company Limited
Acute Mild Basilar Artery Occlusion, Basilar Artery Occlusion
The Efficacy and Safety of Endovascular Treatment for Acute Mild Basilar Artery Occlusion
This study assesses the efficacy and safety of endovascular treatment for acute mild basilar artery occlusion within a multicenter, prospective, open-label, endpoint-blinded, randomized controlled clinical trial.
- Conditions
- Acute Mild Basilar Artery Occlusion, Basilar Artery Occlusion, Endovascular Treatment
- Trial name
- NCT07390032
- Testing
- Endovascular Recanalization Strategy, Best Medical Management
- Where
- China
- Volunteers
- 230 people
- Sponsor
- Feng Gao
Mild Stroke
Tirofiban With Sequential Dual Antiplatelet Therapy in Mild Stroke
This study aims to evaluate whether initiating intravenous tirofiban within 48 hours of onset (with a 48-hour infusion), followed by sequential DAPT, can improve the likelihood of excellent functional outcomes (modified Rankin…
- Trial name
- TiMIS (NCT07095790)
- Testing
- Tirofiban+Oral Dual Antiplatelet Therapy, Oral Dual Antiplatelet Therapy
- Where
- 18 sites in China
- Volunteers
- 580 people
- Sponsor
- Second Affiliated Hospital of Soochow University
Mild Disabling Acute Ischemic Stroke
Effects of Butylphthalide Enhanced With Tenecteplase on Neurological Function in Mild Disabling Acute Ischemic Stroke
Abstract Background Intravenous thrombolysis is the cornerstone of early treatment for acute ischemic stroke (AIS), but some still have a poor prognosis, especially in patients with mild disabling stroke.
- Trial name
- BENEFIT-2 (NCT07369999)
- Testing
- Combination Group, Control Group
- Where
- 15 sites in China
- Volunteers
- 1,062 people
- Sponsor
- Xiangya Hospital of Central South University
Stroke, Ischemic, Cerebrovascular; Disorder, Occlusive
Rescue Endovascular Therapy for Progressive Acute Mild Ischemic Stroke With Large Vascular Occlusion
Endovascular therapy (EVT) added on best medical management is currently recommended in acute large vascular occlusion (LVO) stroke patients with National Institutes of Health Stroke Scale (NIHSS) score >5.
- Trial name
- NCT06155032
- Testing
- Endovascular therapy, Best medical management
- Where
- 7 sites in China
- Volunteers
- 272 people
- Sponsor
- First Affiliated Hospital of Wannan Medical College
Acute Ischemic Stroke, Mild Neurocognitive Disorder
Endovascular Therapy Versus Best Medical Treatment for Acute Large Vessel Occlusion Stroke With Low NIHSS
Patients presenting with mild symptoms of acute ischemic stroke are common and account for approximately half of all acute ischemic stroke. About 30% of patients with minor stroke have a 90-day functional disability.
- Conditions
- Acute Ischemic Stroke, Mild Neurocognitive Disorder, Thrombectomy
- Trial name
- NCT06143488
- Testing
- Endovascular therapy, Best medical management
- Where
- China
- Volunteers
- 264 people
- Sponsor
- First Affiliated Hospital of Wannan Medical College
Acute Mild Ischemic Stroke, Basilar Artery Occlusion
Rescue Endovascular Treatment After Neurological Deterioration in Initially Mild Basilar Artery Occlusion in an Extended Time Window
A prospective, multicenter, open-label, blinded-endpoint, randomized controlled trial to evaluate whether best medical management (BMM) combined with endovascular therapy (EVT) improves neurological outcomes compared to BMM alone…
- Conditions
- Acute Mild Ischemic Stroke, Basilar Artery Occlusion, Rescue Endovascular Treatment, Extended Time Window
- Trial name
- RESCUE-BAO (NCT06843356)
- Testing
- Endovascular Treatment
- Where
- 2 sites in China
- Volunteers
- 159 people
- Sponsor
- First Affiliated Hospital of Wannan Medical College